In 2024, Bangladesh faced an alarming dengue outbreak that overwhelmed healthcare systems, impacted lives, and prompted urgent action. This mosquito-borne viral infection, causing widespread concern annually, reached unprecedented levels, demanding immediate attention and intervention. The Rising
Schrödinger, Inc., a company renowned for its computational software in drug discovery, has navigated the biotech landscape for 35 years while traditionally refraining from associating its platform with artificial intelligence (AI). This distinct approach has set Schrödinger apart from pure
Understanding distinguishing factors between the common cold and flu is crucial for accurate diagnosis, effective treatment, and proper preventive measures. Despite exhibiting similar symptoms, these respiratory illnesses are caused by different viruses and vary significantly in severity. An
Bispecific antibodies (BsAbs) are reshaping targeted therapies with their unique ability to engage two distinct targets simultaneously. This breakthrough innovation significantly diverges from traditional monospecific monoclonal antibodies (mAbs), opening up new avenues for treating various
The article investigates the harmful impact of the Trump Administration's recent policies on global scientific collaboration and research funding, with a particular focus on Australian biomedical research. This analysis highlights the challenges faced by Australian universities and researchers due
Amid mounting concerns regarding government expenditure, federal spending cuts have started to pose a significant threat to critical medical research funding channeled through the National Institutes of Health (NIH). This alarming reduction in financial support is particularly worrying for diseases
